Wednesday 28 December 2016

Medical Devices Report On Inborn Gene or Chromosome Alterations - Pipeline Assessment, 2016




"The Report Inborn Gene or Chromosome Alterations - Medical Devices Pipeline Assessment, 2016 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz"

GlobalData's Medical Devices sector report, Inborn Gene or Chromosome Alterations - Medical Devices Pipeline Assessment, 2016" provides an overview of Inborn Gene or Chromosome Alterations currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Inborn Gene or Chromosome Alterations pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Scope

- Extensive coverage of the Inborn Gene or Chromosome Alterations under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Inborn Gene or Chromosome Alterations and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy

- The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Inborn Gene or Chromosome Alterations under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the products current stage of development, territory and estimated launch date

Download Sample copy of this Report at :

Table of Contents

1 Table of Contents 2
1.1 List of Tables 11
1.2 List of Figures 20
2 Introduction 21
2.1 Inborn Gene or Chromosome Alterations Overview 21
3 Products under Development 22
3.1 Inborn Gene or Chromosome Alterations - Pipeline Products by Stage of Development 22
3.2 Inborn Gene or Chromosome Alterations - Pipeline Products by Territory 23
3.3 Inborn Gene or Chromosome Alterations - Pipeline Products by Regulatory Path 24
3.4 Inborn Gene or Chromosome Alterations - Pipeline Products by Estimated Approval Date 25
3.5 Inborn Gene or Chromosome Alterations - Ongoing Clinical Trials 26
4 Inborn Gene or Chromosome Alterations - Pipeline Products under Development by Companies 27
4.1 Inborn Gene or Chromosome Alterations Companies - Pipeline Products by Stage of Development 27
4.2 Inborn Gene or Chromosome Alterations - Pipeline Products by Stage of Development 31
5 Inborn Gene or Chromosome Alterations Companies and Product Overview 36
5.1 3D Signatures Inc Company Overview 36
5.2 Agena Bioscience, Inc Company Overview 38
5.3 Amarantus Bioscience Holdings Inc Company Overview 39
5.4 Ariosa Diagnostics Inc Company Overview 40
5.5 Atomic International Company Overview 41
5.6 AutoGenomics Inc Company Overview 42
5.7 Avellino Lab USA, Inc. Company Overview 53
5.8 Baylor College of Medicine Company Overview 54
5.9 BCML GmbH Company Overview 55
5.10 BioCeps (Inactive) Company Overview 56
5.11 Celula Inc Company Overview 57
5.12 Children's Hospital Boston Company Overview 58
5.13 Cincinnati Children's Hospital Medical Center Company Overview 60
5.14 Columbia University Company Overview 65
5.15 Da An Gene Co Ltd Company Overview 67
5.16 Deutsches Institut fur Ernahrungsforschung Company Overview 69
5.17 Epinex Diagnostics, Inc. Company Overview 70
5.18 Fina Biotech Company Overview 71
5.19 Firalis SAS Company Overview 72
5.20 Fluidigm Corp Company Overview 73
5.21 Fraunhofer-Gesellschaft zur Forderung der Angewandten Forschung eV Company Overview 75
5.22 Genekam Biotechnology AG Company Overview 76
5.23 Genentech Inc Company Overview 77
5.24 Genetic Analysis AS Company Overview 78
5.25 GENEWIZ Inc Company Overview 80
5.26 German Cancer Research Center Company Overview 81
5.27 GILUPI Nanomedizin Company Overview 83
5.28 Good Start Genetics Inc Company Overview 84
5.29 Goodgene Inc Company Overview 86
5.30 Hadassah Medical Center Company Overview 87
5.31 Helicos BioSciences Corporation Company Overview 88

Read our latest Press Release at http://www.marketresearchreports.biz/pressreleases
About us
MarketResearchReports.biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.

Contact

State Tower
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-621-2074

No comments:

Post a Comment